Diagnostic Accuracy to Detect Hemodynamically Significant Stenosis by Non-invasive SURECardio CT-FFR
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: CT-FFR. CTA. FFR
- Registration Number
- NCT03055780
- Lead Sponsor
- Toshiba Medical Systems Corporation, Japan
- Brief Summary
The aim of this study was to determine the diagnostic accuracy of SURECardio CT-FFR to detect functionally significant coronary stenosis.
- Detailed Description
CT acquision and invasive FFR measurement is performed for each patients. The diagnostic accuracy of coronary CTA and SURECardio CT-FFR is investigated using Invasive FFR is used as the reference standard.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 59
Inclusion Criteria
- suspected coronary artery disease
- hemodynamically stable condition
Exclusion Criteria
- hemodynamic instability
- atrial fibrillation
- morbid obesity (BMI≥40 kg/m2)
- previous stent implantation
- recent myocardial infarction (within 30 days)
- age <40 years
- renal insufficiency (eGFR <60mL/min/1.73m2)
- bronchospastic lung disease requiring long term steroid therapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CT-FFR. CTA. FFR CT-FFR. CTA. FFR 59 patients with suspected CAD that have been scheduled for an interventional FFR study
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of SURECardio CT-FFR to detect functionally significant coronary stenosis one day
- Secondary Outcome Measures
Name Time Method